Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

204 results about "L-alanosine" patented technology

L-alanosine-induced disruption of de novo purine biosynthesis is potentiated by methylthioadenosine phosphorylase (MTAP) deficiency. The clinical use of this agent may be limited by its toxicity profile. MTAP is a key enzyme in the adenine and methionine salvage pathways. from NCIt.

Adhesive DOPA-containing polymers and related methods of use

3,4-Dihydroxyphenyl-L-alanine (DOPA) is an unusual amino acid found in mussel adhesive proteins (MAPs) that form tenacious bonds to various substrates under water. DOPA is believed to be responsible for the adhesive characteristics of MAPs. This invention relates to a route for the conjugation of DOPA moieties to various polymeric systems, including but not limited to poly(ethylene glycol) or poly(alkylene oxide) systems such as poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) block copolymers.
Owner:NORTHWESTERN UNIV

Prostate formula

A composition providing an all-natural, non-surgical preventative of or improvement to disorders of the prostate gland is described. The invention relates to a composition for the prevention of or improvement of prostatitis, and for relieving symptoms and improving objective signs of prostatitis. The formula of the composition preferably includes the following ingredients each in a therapeutically effective amount: Vitamin C, Vitamin B6, Vitamin E, zinc, glycine, L-alanine, Glutamic acid, Saw palmetto, Pygeum extract, Pumpkin seed, Stinging nettle, Echinacea, garlic, Ginkgo leaves, and selenium.
Owner:WHEELER RONALD E

Composition for an in vitro fertilization medium

PCT No. PCT / JP96 / 02503 Sec. 371 Date Mar. 2, 1998 Sec. 102(e) Date Mar. 2, 1998 PCT Filed Sep. 4, 1996 PCT Pub. No. WO97 / 08946 PCT Pub. Date Mar. 13, 1997The present invention aims to provide a medium composition for in vitro fertilization, in particular, a composition usable in the culture of ova or early embryos which are fertilized eggs, the preparation or culture of sperm, and the pre-treatment of ova or sperm. The composition comprises, as its essential components, L-phenylalanine, L-tryptophan, L-lysine, L-threonine, L-valine, L-methionine, L-isoleucine, L-leucine, L-proline, glycine, L-alanine, L-tyrosine, L-histidine, L-arginine, L-taurine, L-aspartic acid, L-serine, L-asparagine, L-glutamic acid, L-glutamine and L-cystine, provided that at least a part of the L-cystine may be replaced by L-cysteine.
Owner:FUSO PHARMA INDS

Preparation method of 3,5-dibenzoyl-2-deoxy-2-fluoro-2-methyl-D-ribo-gamma-lactone

The invention provides a preparation method of 3,5-dibenzoyl-2-deoxy-2-fluoro-2-methyl-D-ribo-gamma-lactone (sofosbuvir). The method comprises the following steps: adding alkali into a mixed solution of L-alanine isopropyl ester or an acid salt thereof and phenyl dichlorophosphate for reacting to obtain (S)-2-phenoxy-chloro-phosphoryl amino isopropyl propionate, reacting the (S)-2-phenoxy-chloro-phosphoryl amino isopropyl propionate with 4-trifluoromethylphenol in the presence of alkali at the temperature of 0-10 DEG C to obtain racemic (S)-2-[(4-trifluoromethyl-phenoxyl)-phenoxy-phosphoryl amino)]alanine isopropyl ester, dissolving the racemic (S)-2-[(4-trifluoromethyl-phenoxyl)-phenoxy-phosphoryl amino)]alanine isopropyl ester into an ether or alkane solvent at the normal temperature, cooling to 50-10 DEG C below zero, and separating (S)-2-[(S)-(4-trifluoromethyl-phenoxy)]-phenoxy-phosphoryl amino)]alanine isopropyl ester out; and reacting the (S)-2-[(S)-(4-trifluoromethyl-phenoxy)]-phenoxy-phosphoryl amino)]alanine isopropyl ester with (2'R)-2'-deoxy-2'-fluoro-2'-methyluridine in the presence of organic alkali with high steric hindrance to obtain the 3,5-dibenzoyl-2-deoxy-2-fluoro-2-methyl-D-ribo-gamma-lactone. The method has the advantages of simple steps, mild reaction and suitability for industrial production.
Owner:苏州东南药业股份有限公司

XZ-A26 bacterial strain for producing L-alanine with high yield as well as construction method and application of XZ-A26 bacterial strain

The invention discloses an XZ-A26 bacterial strain for producing L-alanine with high yield, which has a preservation number of CGMCC (China General Microbiological Culture Collection Center) No.4036 and has the capacity of generating high-concentration L-alanine through fermentation. The XZ-A26 bacterial strain is constructed by the steps of: integrating an L-alanine dehydrogenase gene on thermophilic fatty bacillus chromosome on lactic dehydrogenase position on an escherichia coli ATCC8739 chromosome, then sequentially knocking out a pyruvate formate lyase gene, an alcohol dehydrogenase gene, an acetokinase gene, a fumaric acid reductase gene and an alanine racemase gene of the escherichia coli chromosome, and then carrying out continuous cell culture in a fermenting tank for obtaining agenetic engineering strain. The invention also relates to a construction method of the XZ-A26 bacterial strain and an application of the XZ-A26 bacterial strain in preparation of the L-alanine. According to the invention, the escherichia coli with the preservation number of CGMCC No.4036 for generating the high-concentration L-alanine through fermentation can be constructed by using a metabolic engineering method, and the yield of the L-alanine generated by using the XZ-A26 bacterial strain reaches up to 115g / L. The XZ-A26 bacterial strain is suitable for industrially producing the L-alanine.
Owner:ANHUI HUAHENG BIOTECH

Method for suppressing multiple drug resistance in cancer cells

Methods for treating and preventing the onset and maintainance of multiple drug resistance (MDR) in animals undergoing chemotherapy for cancer are provided. According to the methods, target cells are depleted of adenosine 5'-monophosphate (AMP) and adenosine 5'-triphosphate (ATP) such that the cells are unable to support P-glycoprotein activity. According to one method, a population of target cells is obtained from a host and assayed for loss of methylthioadenosine phosphorylase (MTAse) activity. MTAse catabolizes methylthioadenosine to adenine for endogenous salvage incorporation into the intracellular AMP pool. MTAse deficient cells are treated with a purine synthesis inhibitor, such as L-alanosine, which starves the cells of adenine and suppresses P-glycoprotein activity. MTAse competent cells are also treated for MDR with purine synthesis inhibitors. In conjunction with treatment according to the invention, MTAse competent and deficient cells are also treated for malignancy with other anti-cancer drugs. A method for protecting non-malignant cells from adenine starvation during treatment of malignant cells according to the invention is provided.
Owner:RGT UNIV OF CALIFORNIA

Preparation method of ribofuranose phosphate derivative

The invention discloses a preparation method of a ribofuranose phosphate derivative. The preparation method comprises preparation steps as follows: L-alanine isopropyl ester hydrochloride, phenol dichlorophosphate and substituted phenol are taken as starting materials and have a docking reaction under the action of alkali; (2R)-2-deoxy-2-difluoro-2-methyl-D-erythropentonic acid GAMMA-lactone and 3,5-dibenzoate reduce carbonyl in a dichloromethane or ether solvent into an alcoholic hydroxyl group under the action of a strong reducing agent; an intermediate with a formula 2-1 has a reaction with paratoluensulfonyl chloride under the action of alkali to obtain p-toluenesulfonates; an intermediate with a formula 2-2 and a benzoyl cytosine derivative have a docking reaction under the action of a condensing agent; an intermediate with a formula 2-3 converts cytosine into uracil under the action of organic acid; benzoyl protection for an intermediate with a formula 2-4 is released under the action of an alkaline agent; an intermediate with a formula 2-5 and an intermediate with a formula 1 are docked under the action of a Grignard reagent to obtain Sofosbuvir.
Owner:NANTONG CHANGYOO PHARMATECH CO LTD

Preparation method of semaglutide and intermediate of semaglutide

The invention belongs to the technical field of pharmaceutical chemistry, and discloses a preparation method of semaglutide and an intermediate of semaglutide. The preparation method comprises: obtaining a compound having a structure represented as the formula I by taking a resin, activating the resin, and coupling L-glycine, L-arginine, L-glycine, L-arginine, L-valine, L- leucine, L-tryptophan, L-alanine, L-isoleucine, L-phenylalanine, and L-glutamic acid to the activated resin step by step so as to obtain a first peptide resin; taking the first peptide resin, and coupling amino acids or amino acid derivatives to the second peptide resin step by step; and taking the second peptide resin, and performing cracking and purifying to obtain semaglutide. According to the method, the compound having a structure represented as the formula I is taken as an intermediate and coupling of each amino acid or amino acid derivative step by step through solid-phase synthesis is carried out, thereby improving the yield of semaglutide. In the formula I, R1 is selected from Fmoc, Boc, and ivDde, and R2 is selected from tBu, Dmab, and Bzl.
Owner:HYBIO PHARMA

Method for preparing alanyl-glutamine dipeptide through biological enzyme conversion

InactiveCN105274174AHigh activityImprove catalytic conversion effectFermentationTemperature controlReaction rate
The invention relates to the technical field of the preparation for alanyl-glutamine dipeptide and particularly discloses a method for preparing alanyl-glutamine dipeptide through biological enzyme conversion. The method comprises the following steps: 1) preparing a biological enzyme liquid: dissolving the biological enzyme in a buffered liquid, controlling pH value within the scope of 7.0+ / -2.0, controlling the temperature at 5-10 DEG C, thereby acquiring the biological enzyme liquid, wherein the mass fraction of the ester acyl-containing transferring biological enzyme is 5%-20%; 2) dissolving the ester derivates of substrate L-alanine and glutamine in pure water, and then uniformly dropping the biological enzyme liquid into a reaction liquor, and meanwhile, adding acid liquor or alkali liquor, controlling the pH of the reaction liquor at 5-10, reacting under the temperature controlled at 15-25 DEG C, sampling and detecting the production of the alanyl-glutamine dipeptide during the reaction process, stopping reaction when the content of the alanyl-glutamine dipeptide is highest, and separating the acquired converted liquid, thereby acquiring the alanyl-glutamine dipeptide. According to the method provided by the invention, the enzyme activity is high, the reaction rate of the materials is higher, the method has the advantages of simple technique control, easy control on quality index and low cost, and the method is more fit for industrial production.
Owner:JING JING PHARMA

Industrial production method of high-purity N-lauroyl-L-alanine surfactant

The invention discloses an industrial production method of a high-purity N-lauroyl-L-alanine surfactant, which comprises the following steps: A, dissolving a certain amount of alanine and a metal inorganic base in a certain amount of mixed solvents of distilled water and organic solvents to prepare an alanine salt; B, slowly and dropwisely adding metered lauroyl chloride into the reaction solution at a certain temperature, dropwisely adding the metal inorganic base solution with a certain concentration to maintain the pH value of the reaction system to be a specified value, after the dropwise addition, continuing to stirring for a specified time to generate an N-lauroyl-L-alanine salt; C, after the reaction is stopped, acidifying the product with dilute hydrochloric acid to obtain a pH of 3-4, precipitating solids, performing suction filtration, stirring and washing the obtained solid with water twice, performing recrystallization of the crude product with a solvent, performing heating reflux, cooling, filtration, and drying to obtain white powdery N-lauroyl-L-alanine with high purity of more than 98%. The method of the invention is simple, practical, low in cost, high in production efficiency, and suitable for industrial production.
Owner:SUZHOU WEIMEI BIOLOGICAL TECH

Amino acid composite reinforcement method for rotten silk cultural relics

The invention relates to an amino acid composite reinforcement method for rotten silk cultural relics, which is characterized by comprising the following steps: A) using a spraying device to uniformly spray amino acid solution with the mass percentage concentration being 0.5-2 percent onto the surfaces of the rotten silk cultural relics until water can drop down; wherein the amino acid is one of L-cysteine, L-alanine, L-lysine, L-histidine and L-arginine; and B) waiting for 10min after completion of Step A, uniformly spraying ethylene glycol diglycidyl ether solution with the mass percentage concentration being 1.5-3 percent onto the surfaces of the rotten silk cultural relics until water can drop down, and naturally drying the rotten silk cultural relics, thereby reinforcing the rotten silk cultural relics. Compared with the prior art, the method has the advantages that: 1) the operation is more convenient; and 2) the reinforcing effect is obviously better than the effect of the original method, the operation is more convenient and complies with the requirements and concepts of bionic reinforcement.
Owner:ZHEJIANG SCI-TECH UNIV

Escherichia coli for efficiently producing L-alanine by fermentation

The invention discloses escherichia coli for efficiently producing L-alanine by fermentation, and belongs to the technical field of microbial metabolic engineering. Coding genes for a synthesis route for byproducts acetic acid, formic acid, alcohol, succinic acid and lactic acid on a chromosome of escherichia coli CGMCC No.10628 provided by the invention are deleted, and the chromosome dadX gene is replaced as an alanine dehydrogenase gene, wherein the coding genes comprise ackA-pta, pflB, adhE, frdA and idhA. The recombinant bacterium is fermented for 26 hours to produce 106g / L or more than 106g / L L-alanine with high optical purity and high chemical purity at 28-45 DEG C; and in the whole fermentation process, the production strength reaches 4.27g / L.h or more.
Owner:JIANGNAN UNIV

Composition for relieving physical fatigue and enhancing immunologic function, preparation method thereof and application thereof

The invention discloses a composition for relieving physical fatigue and enhancing an immunologic function, a preparation method thereof and application thereof. The composite comprises 10 to 100 weight parts of guarana extract, 100 to 800 weight parts of taurine, 1 to 10 weight parts of L-lysine hydrochloride, 1 to 10 weight parts of L-isoleucine, 0.1 to 5 weight parts of L-leucine, 0.2 to 5 weight parts of L-valine, 1 to 15 weight parts of L-aspartate, 0.01 to 0.3 weight part of L-tryptophan, 0.01 to 0.3 weight part of L-phenylalanine, 0.01 to 0.3 weight part of L-threonine, 0.01 to 0.3 weight part of L-methionine, 10 to 100 weight parts of L-alanine, 10 to 100 weight parts of glycine, 1 to 15 weight parts of tea polyphenol and 1 to 20 weight parts of American ginseng extract.
Owner:上海东锦食品集团有限公司 +1

Healthcare product for relieving hangover and protecting liver

The invention relates to a healthcare product for relieving hangover and protecting liver. The healthcare product comprises the following materials based on ratio: 1 to 10 parts of acetaldehyde dehydrogenase enzymic preparation, 20 to 50 parts of pueraria extract, 10 to 30 parts of ginseng extract, 5 to 15 parts of acanthopanax senticosus extract, 5 to 10 parts of langehead atractylodes rhizome extract, 10 to 15 parts of lycium barbarum extract, 20 to 40 parts of hovenia dulcis thumb, 0 to 2 parts of vitamin B1, 0 to 2 parts of vitamin B2, 0 to 1 part of vitamin B6, 1 to 5 parts of vitamin C, 0 to 1 part of L-glycine, 1 to 2 parts of L-cysteine, and 0 to 2 parts of L-alanine. The healthcare product comprises the following functions: 1, the hangover is relieved, and the recovery after drink is sped up; 2, various symptoms after drink are relieved, the inbibitional effect of alcohol to nervous centralis is reduced, and the conscious can be effectively maintained; 3, the effect of detoxifying the liver is improved, the lipid peroxidation reaction is inhibited, the damage of the alcohol to the liver is reduced, and the regeneration capacity of the stem cells is improved; and 4, the simulation of the alcohol to the stomach is relieved.
Owner:WUHAN INSTITUTE OF TECHNOLOGY +1

Engineering bacteria producing DL-alanine and method of producing DL-alanine by using engineering bacteria

The invention discloses a strain of engineering bacteria producing DL-alanine. Lactic dehydrogenase, pyruvate formate lyase, alcohol dehydrogenase, acetic acid kinase, fumaric acid reductase, alanine racemase and methyl glyoxal synthetase of the strain of engineering bacteria producing the DL-alanine are inactivated; and exogenous L-alanine dehydrogenase gene and alanine racemase gene are integrated on the chromosome of the engineering bacteria. According to the invention, pyroracemic acid, an intermediate product of the glycolysis is converted to L-alanine by integrating the exogenous L-alanine dehydrogenase gene into the chromosome of the engineering bacteria; and an exogenous alanine racemase gene is further integrated into the chromosome, and part of the L-alanine is converted into D-alanine. Then producing the DL-alanine from raw material sugar in one step is realized, the production period of the DL-alanine is decreased and the productivity of the DL-alanine is enhanced.
Owner:ANHUI HUAHENG BIOTECH

Barbary wolfberry fruit chicken essence and production method thereof

InactiveCN102429198APreserve Natural FragrancePreserve nutrientsFood preparationL-alanosineFood science
The invention discloses barbary wolfberry fruit chicken essence, which comprises barbary wolfberry fruit, sodium glutamate, edible salt, edible corn starch, white granulated sugar, maltodextrin, chicken powder, chicken extract seasoning, L-lactamine, disodium succinate, aminoacetic acid, curry powder, spices, wheat extract powder, eggs, flavor-developing nucleotide disodium, edible essence and spices and curcuma in the weight ratio of 10:38:12:4.5:6:5.5:4:5:1.4:1.5:1.3:1.5:1.1:1.8:1.3:1.5:1.7:1.9. The invention further provides a method for producing the barbary wolfberry fruit chicken essence.
Owner:NINGXIA JINDAO FOOD

L-alanine-(14-oridonin) ester trifluoroacetate as well as preparation method and application thereof

The invention relates to L-alanine-(14-oridonin) ester trifluoroacetate as well as a preparation method and application thereof. The preparation method of the compound comprises the following steps of: by taking oridonin (II) as a starting material, generating 14-position esterification reaction with N-BOC-L-alanine in the presence of DCC to obtain N-BOC-L-alanine oridonin ester (III), removing a BOC protective group in trifluoroacetic acid, and salt-forming to obtain L-alanine-(14-oridonin) ester trifluoroacetate (I). The compound can be applied to clinic very well, and is used for treating esophagus cancer, gastric cancer, primary liver cancer, pancreatic cancer, cardia cancer, colorectal cancer, bladder cancer, breast cancer, acute myelogenous leukemia, and the like.
Owner:JIANGSU HENGRUI MEDICINE CO LTD +1

Composite for disintoxicating and sobering

The invention discloses a composite (B) for disintoxicating and sobering, which is prepared by glucose and fructose, fruit glucose, honey, L-cysteine, L-alanine, L-ornithine, L-glutamine, L-carnitine according to a certain weight range. In order to enable the effect better, one or more of taurine, L-asparaginic acid or L-aspartate, vitamin B1, vitamin B6, caffeine, L-arginine, L-glutamic acid, L-proline, phaseomannite, vitamin B2, nicotinic acid, folic acid, vitamin B12 and pantothenic acid are also added. The composite can be prepared into liquid preparation and electuary. The composite of the invention can be prepared into food and health food. The invention can quickly disintoxicate, sober, eliminate alcoholism symptom and continued effect of alcohol on a human body, and has no side effect.
Owner:克科

Detection reagent for alanine aminotransferase

The invention discloses a detection reagent for alanine aminotransferase. The detection reagent comprises a diluent and a reaction reagent. The diluent comprises a buffer, a surfactant, an antiseptic, a bilirubin-interference removing reagent, and an ascorbic oxidase. The reaction reagent comprises a buffer, L-alanine, alpha-ketoglutaric acid, phosphoric acid, pyruvate oxidase, thiamine pyrophosphate, magnesium chloride, peroxidase, 4-aminoantipyrene, a chromogen, an antiseptic, and a freeze-drying protecting agent. The detection reagent has advantages of good sensitivity, accuracy, precision and linearity, and can completely meet the requirements of clinical examination.
Owner:NINGBO MEDICAL SYSTEM BIOTECHNOLOGY CO LTD

L-alanine dehydrogenase mutant zymoprotein and preparation method thereof

The present invention discloses L-alanine dehydrogenase mutant zymoprotein and a preparation method thereof. According to a homologous sequence secondary structure comparison result, site-specific mutagenesis of 73th lysine near an L-alanine dehydrogenase activity center of Bacilluspseudofirmus into alanine through PCR is performed to construct a mutant expression vector, and prokaryotic expression and Ni-NTA affinity chromatography purification are performed to obtain a mutant enzyme K73A, wherein specific activity of the obtained mutant enzyme K73A is 202% of specific activity the wild type, and other enzymatic properties are not changed. In addition, a turnover number Kcat on a substrate L-alanine by the mutant zymoprotein is 376.7 min<-1> and is 2.0 times the turnover number Kcat of the wild type, a turnover number Kcat on beta-NAD<+> by the mutant zymoprotein is 290.1 min<-1> and is 2.1 times the turnover number Kcat of the wild type, and the mutant zymoprotein can be applicable for production processes of production of pyruvic acid, L / D-alanine, and the like through improvement biology methods.
Owner:HEBEI NORMAL UNIV

Process for the preparation of a polypeptide

A process for the preparation of a polypeptide made from amino acids L-alanine, L-glutamic acid, L-lysine, and L-tyrosine comprising using N-thiocarboxyanhydride of at least one amino acid as a starting material.
Owner:SCINOPHARM TAIWAN LTD

Bacillus amyloliquefaciens insecticide-fertilizer for farm onsite fermentation and applications thereof

The invention relates to a bacillus amyloliquefaciens insecticide-fertilizer for farm onsite fermentation, a preparation method and applications thereof. The insecticide-fertilizer comprises the following raw materials: bacillus amyloliquefaciens, colistin sulfate, natamycin, L-alanine, asparagine, yeast extract powder, peptone, disodium hydrogen phosphate, sodium chloride, glucose, fructose, and brown sugar. The colistin sulfate and natamycin in the insecticide-fertilizer can inhibit the growth of fungi (such as pathogenic fungi, yeast, etc.) and gram negative bacteria (such as colibacillus, salmonella, etc.) during the fermentation process. The spore germinator (alanine, fructose, and asparagine) can rapidly promote the germination of spores of bacillus amyloliquefaciens and improve the germination rate of spores. The provided insecticide-fertilizer can be applied to the onsite fermentation and propagation in a simple and crude farm. The required equipment is simple. The using amount of bacterium is little. The cost is low. The fermentation broth obtained through onsite fermentation has the advantages of high content and good activity. The insecticide-fertilizer can prevent disease, promote growth, and increase output and improve quality, and can be used as a microbial pesticide, and the effect is stable.
Owner:FOSHAN YANHUI BIOTECH CO LTD

Method of producing L-alanyl-L-glutamine from recombinant escherichia coli

The invention discloses a method of producing L-alanyl-L-glutamine from recombinant escherichia coli, wherein the method of producing L-alanyl-L-glutamine from recombinant escherichia coli is follows: in an aqueous solution with a determined pH value, acting on free L-glutamine and L-alanine methyl ester hydrochloride to generate L-alanyl-L-glutamine, recombining a gene segment of the protein with the amino-acid ester acyltransferase of the L-alanyl-L-glutamine into a carrier and transferring into host bacteria, thereby obtaining the host bacteria with the recombinant DNA and capable of strengthening the activity of an L-alanyl-L-glutamine biological synthesis system. The method comprises the following steps: (1) culturing a larger number of recombinant escherichia coli cells for expressing the amino-acid ester acyltransferase; (2) excessively expressing the amino-acid ester acyltransferase in the step (1); and (3) taking the amino-acid ester acyltransferase in the step (2) as a crude enzyme source, adding the crude enzyme source into a buffer solution containing L-glutamine and L-alanine methyl ester hydrochloride substrate amino acid to react, thereby realizing efficient production of the L-alanyl-L-glutamine.
Owner:JIANGNAN UNIV

Biocatalysis method for preparing pyruvic acid from L-alanine

The invention provides a biocatalysis method for preparing pyruvic acid from L-alanine. The method comprises the steps of: carrying out permeability treatment on Alcaligens faecalisl.1799 cells; catalyzing oxidative deamination of L-alanine by utilizing L-amino acid oxidase in the cells in the presence of air to form pyruvic acid, ammonia and hydrogen peroxide; catalyzing the hydrogen peroxide formed in the reaction by utilizing catalase in the cells to realize pyruvic acid accumulation without producing by-products. The method provided by the invention has the advantages of low cost, high product yield and purity and environment friendliness, and is suitable for industrial production of pyruvic acid.
Owner:CHONGQING UNIV OF POSTS & TELECOMM +1

Methods for treating therapy-resistant tumors

This invention provides methods for using novel substituted pyrimidine compounds, derivatives and analogs thereof to treat diseases such as cancer. Examples of compounds and derivatives for use in the methods are (E)-5-(2-bromovinyl)-2′-deoxy-5′-uridyl phenyl L-alaninylphosphoramidate and (E)-5-(2-bromovinyl)-2′-deoxy-5′-uridyl phenyl L-alaninyl monophosphate.
Owner:CELMED ONCOLOGY USA

HPLC (high performance liquid chromatography) detection method for simultaneously determining five substances in reaction system for producing L-Ala-L-Gln (L-alanyl-L-glutamine) with microbial enzyme method

The invention discloses an HPLC (high performance liquid chromatography) detection method for simultaneously determining five substances (L-Ala-L-Gln (L-alanyl-L-glutamine), L-Gln, L-AlaOMe, L-Glu and L-alanyl-L-alanine) in a reaction system for producing L-Ala-L-Gln with a microbial enzyme method. The five substances are subjected to pre-column automatic derivatization treatment by ortho-phthaladehyde, so that the five substances have fluorescence groups and are detected by a fluorescence detector. The chromatographic condition is as follows: a high performance liquid chromatograph Agilent 1260 Infinity is adopted; an Agilent ZORBAX SB-Aq, 5 mu m, 4.6*250 mm C18 column is adopted as a chromatographic column; an Agilent 1260 Infinity fluorescence detector is adopted; a mobile phase comprises acetonitrile and a phosphate buffer solution in the volume ratio being 12:88, and the pH of the mobile phase is adjusted to 7.4 by the aid of phosphoric acid; the flow velocity of the mobile phase is 1.0 ml / min; the column room temperature is 40 DEG C; detection wavelength comprises excitation wavelength Ex 338 nm and emission wavelength Em 450 nm. The method realizes simultaneous determination of oligopeptide, amino acid and amino derivatives, is simple to operate and high in sensitivity and has important application value.
Owner:JIANGNAN UNIV

Paenibacillus polymyxa pesticide-fertilizer for farm onsite fermentation and applications thereof

The invention relates to a paenibacillus polymyxa pesticide-fertilizer for farm onsite fermentation, a preparation method, and applications thereof. The pesticide-fertilizer comprises the following raw materials: paenibacillus polymyxa powder, colistin sulfate, natamycin, L-alanine, valine, yeast powder, corn steep liquor powder, disodium hydrogen phosphate, sodium chloride, fructose, and brown sugar. The colistin sulfate and natamycin in the insecticide-fertilizer can inhibit the growth of fungi (such as pathogenic fungi, yeast, etc.) and gram negative bacteria (such as colibacillus, salmonella, etc.) during the fermentation process. The spore germinator (alanine, fructose, and valine) can rapidly promote the germination of spores of paenibacillus polymyxa and improve the germination rate of spores. The provided pesticide-fertilizer can be applied to the onsite fermentation and propagation in a simple and crude farm. The required equipment is simple. The using amount of bacterium is little. The cost is low. The fermentation broth obtained through onsite fermentation has the advantages of high content and good activity. The insecticide-fertilizer can prevent disease, promote growth, and increase output and improve product quality, and can be used as a microbial pesticide, and the effect is stable.
Owner:FOSHAN YANHUI BIOTECH CO LTD

Escherichia coli capable of producing L-alanine through fermentation and application of escherichia coli

The invention discloses escherichia coli capable of producing L-alanine through fermentation and application of the escherichia coli and belongs to the technical field of biological engineering. According to the escherichia coli, aspartase AspA and L-aspartic acid-beta-decarboxylase AsD are introduced into the escherichia coli capable of producing fumaric acid through the fermentation; furthermore, a YgaW gene is over-expressed to strengthen the transport ability of the L-alanine in recombinant bacteria, so that a novel strain capable of fermenting glucose to produce the L-alanine is constructed; when the recombinant strain is fermented in a fermentation tank for 45h, the yield of the L-alanine reaches 147g / L and the saccharic acid conversion rate is 79.0 percent.
Owner:金华利家园生物工程有限公司 +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products